Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren/Amlodipine in African American Patients with Stage 2 Hypertension
NCT00853957Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00853957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853957.